logo-loader
NASDAQ:CADL

Candel Therapeutics Inc

Receive alerts
Market:
NASDAQ
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer.

The company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. 

Snapshot

  • Candel Therapeutics teams up with EVERSANA to prep for prostate cancer drug launch
  • Candel Therapeutics reports Phase 2 trial shows extended survival in Pancreatic Cancer